Can Nesfatin-1 Predict Hypertension in Obese Children?


Creative Commons License

Gunes H. , Baylan F. A. , Gunes H., Temiz F.

JOURNAL OF CLINICAL RESEARCH IN PEDIATRIC ENDOCRINOLOGY, vol.12, no.1, pp.29-36, 2020 (Journal Indexed in SCI) identifier identifier identifier

  • Publication Type: Article / Article
  • Volume: 12 Issue: 1
  • Publication Date: 2020
  • Doi Number: 10.4274/jcrpe.galenos.2019.2019.0072
  • Title of Journal : JOURNAL OF CLINICAL RESEARCH IN PEDIATRIC ENDOCRINOLOGY
  • Page Numbers: pp.29-36
  • Keywords: Obesity, hypertension, Nesfatin-I, children, SYMPATHETIC-NERVE ACTIVITY, CONVERTING-ENZYME, AGED HYPERTENSION, SATIETY MOLECULE, BODY-COMPOSITION, BLOOD-PRESSURE, FOOD-INTAKE, OVERWEIGHT, COPPER, BRAIN

Abstract

Objective: The prevalence of childhood obesity is increasing and leads to co-morbidities such as hypertension. However, it is still not clear why some obese individuals are hypertensive and others not. Nesfatin-1 is a recently discovered anorexigenic peptide which also has effects on blood pressure (BP). Our aim was to evaluate the relationship between obesity-related hypertension and Nesfatin-1.